Ritedapag

Stallion Laboratories Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 0d944ebc19bb3f90
Drug Approval Philippines Name: Ritedapag
Product Name: Ritedapag
Registration Number: DRP-15483-07
Brand Name: Ritedapag
Generic Name: Dapagliflozin (as propanediol monohydrate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 10 mg
Manufacturer: Stallion Laboratories Pvt. Ltd.
Importer: Ambica International Corporation
Distributor: Diafarm Inc.
Issuance Date: 27 October 2024
Expiry Date: 16 July 2029
Pharmacologic Category: Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0d944ebc19bb3f90

Type

Standard